The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation

BACKGROUND: The impact of cerebral microbleeds on the safety of antithrombotic therapy has recently received considerable attention. We investigated the safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism caused by nonvalvular atrial fibrillation....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiayu, Zhang, Jia, Shen, Yuan, Xu, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444618/
https://www.ncbi.nlm.nih.gov/pubmed/30940095
http://dx.doi.org/10.1186/s12872-019-1046-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444618/
https://www.ncbi.nlm.nih.gov/pubmed/30940095
http://dx.doi.org/10.1186/s12872-019-1046-y

Ejemplares similares